Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling sick on Mounjaro is one of the most commonly reported experiences, particularly in the first few weeks of treatment or after a dose increase. Nausea affects a significant proportion of users and is directly linked to how tirzepatide works in the body — it slows the rate at which your stomach empties, which increases feelings of fullness but can also trigger queasiness. The good news is that for most people it settles. It rarely means you have to stop. As a prescription-only medicine, Mounjaro is clinically assessed before and throughout treatment, so if nausea is affecting your quality of life, that conversation belongs with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) that are naturally involved in regulating hunger and blood-sugar levels. One of its effects is to slow gastric emptying: food sits in the stomach for longer, which is partly why appetite falls. The downside is that a fuller stomach signals nausea. This is not a sign that something has gone wrong. It is the same biological pathway producing both the therapeutic benefit and the unwanted queasiness.
A common misconception worth clearing up: many people assume nausea means the dose is too high or that they are reacting badly to the medicine. In most cases, neither is true. The starter dose is specifically set at 2.5mg to help the body adapt, not because higher doses are dangerous from day one, it is a deliberate tolerance-building step. Nausea at that level is still normal for some people, and it does not predict how you will respond long-term. The full side-effect picture for Mounjaro covers more than nausea alone, but queasiness is the one people notice first.
According to NHS guidance on tirzepatide, nausea is listed among the most common side effects, alongside vomiting, diarrhoea and constipation. These are GI-led and generally most pronounced at the start of treatment or after stepping up to a higher dose.
For most people, nausea is sharpest in the first several days after starting a new dose and tends to ease as the body adapts. A rough pattern: noticeable discomfort for a few days, then improvement over one to two weeks. By the time the next dose increase arrives, many people have already adjusted to their current level.
Nausea that lingers well beyond two weeks, or that suddenly returns in full force mid-dose cycle, is worth raising with your prescriber. It might prompt a slower titration schedule, or a closer look at what you are eating and when. If Mounjaro is also leaving you feeling unusually fatigued, that combination is also worth mentioning, fatigue and nausea together can compound quickly.
There is individual variation here. Some people barely notice any nausea at all. Others find it difficult for several weeks. Neither experience is a reliable predictor of how well the treatment is working. Weight loss results in clinical trials were not correlated with the severity of GI side effects, feeling worse does not mean the medicine is doing more.
Small adjustments to eating habits tend to make the biggest difference. Eating smaller portions more frequently (rather than large meals) reduces the demand on a stomach that is already emptying slowly. Very fatty or greasy foods amplify gastric fullness and are best avoided, particularly around the time of your injection. Spicy food is another common trigger while you are adjusting.
Staying well hydrated matters. Nausea makes it tempting to avoid drinking, but dehydration makes queasiness worse. Sipping water steadily throughout the day, rather than drinking large amounts at once, is easier on the stomach. Ginger (in tea or as a food) has a long history of use for nausea and is generally well tolerated, though it will not eliminate the symptom entirely.
Injection timing can also play a role. Some people find taking their weekly dose in the evening means the peak of any nausea arrives while they are asleep. Others prefer a weekend morning so they can rest if needed. There is no single right answer; it is a practical experiment. If you are looking at the broader question of what to expect before you start, a detailed look at who is most likely to feel sick on Mounjaro covers the risk factors.
For a broader sense of what treatment costs and what is included in a private prescription, the Mounjaro cost page sets out the current picture plainly.
Most nausea on tirzepatide is uncomfortable but not dangerous. There are situations, however, where you should seek medical help without delay rather than waiting to see if it passes.
Severe abdominal pain (particularly pain that is persistent and radiates towards the back) combined with nausea or vomiting warrants urgent attention. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; the symptom pattern to watch for is exactly this: significant stomach pain that does not ease, with or without vomiting. You can report any suspected side effect directly via the MHRA Yellow Card scheme.
Vomiting so severe that you cannot keep fluids down is another situation requiring prompt contact with a healthcare professional. Dehydration from prolonged vomiting can affect kidney function and becomes a medical concern in its own right. If you are experiencing nausea alongside constipation or other GI symptoms that are difficult to manage, your prescriber can advise on whether the pace of titration needs to change.
If you have questions about whether Mounjaro is right for your situation, our prescribers at nume's free consultation review every case individually before treatment begins, and remain available throughout.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.